Selected Abstracts

MS disease activity inhibits hepatocyte growth factor (HGF) production within the CNS - a new putative mechanism contributing to lack of lesion repair seen in MS

A.M. Mueller, E. Jun, H. Conlon, S. Sadiq. Nov 14th 2011. Platform presentation at the 2011 meeting of the Society for Neuroscience, Washington DC, USA.

Read Abstract

Human mesenchymal stem cell-derived neural progenitors (MSC-NPs) exhibit trophic properties that may influence repair in MS

Raihan Faroqui, Violaine K. Harris, Tamara Vyshkina, and Saud A. Sadiq. Presented at the 5th joint congress of ECTRIMS and ACTRIMS meeting held October 19-22, 2011 in Amsterdam.

Read Abstract

CSF biomarker profiles of MS patients treated with intrathecal methotrexate (ITMTX)

Amir Touray, Violaine K. Harris, and Saud A. Sadiq. Presented at the 5th joint congress of ECTRIMS and ACTRIMS meeting held October 19-22, 2011 in Amsterdam.

Read Abstract

Intrathecal methotrexate (ITMTX) reduces astrogliosis in a non-inflammatory demyelination model

Hana Conlon, André Müller, Xinhe Liu , Esther Jun, Saud Sadiq. Presented at the 5th joint congress of ECTRIMS and ACTRIMS meeting held October 19-22, 2011 in Amsterdam.

Read Abstract

Elevated cerebrospinal fluid levels of an isoprostane, an oxidative stress biomarker in MS patients

Fozia Mir and Saud A. Sadiq. Presented at the 5th joint congress of ECTRIMS and ACTRIMS meeting held October 19-22, 2011 in Amsterdam.

Read Abstract

Safety of Long-term Intrathecal Methotrexate Therapy in Progressive Forms of Multiple Sclerosis

James W. Stark, MD, Laura Leuenberger and Saud A. Sadiq, MD. Presented at the 5th joint congress of ECTRIMS and ACTRIMS meeting held October 19-22, 2011 in Amsterdam.

Read Abstract

Abstracts archive

Pages

Tisch MS Research Center of New York

521 West 57th Street
4th Floor
New York, NY 10019
(646) 557-3900

Privacy Policy

 

Support Tisch MS

Support Tisch MS and our innovative research leading to treatments that improve the lives of patients.